Answers are grounded in this paper and cite their sources.
Older residents of long-term care facilities (LTCFs) are increasingly treated with complex pharmacotherapy while living with frailty, malnutrition, inflammation, recurrent infection, and reduced physiological reserve. Medication safety in this population cannot rely only on chronological age, diagnostic labels, renal function, or medication counts. This article proposes a translational framework in which serum zinc and albumin are interpreted with frailty and medication review to identify residents at increased risk of adverse drug reactions, infection-related prescribing, and prescribing cascades. Zinc links nutritional status with immune signaling, antioxidant defense, tissue repair, protein synthesis, and gene-regulatory pathways, whereas albumin links plasma zinc transport, inflammation, and pharmacokinetic vulnerability. Because both markers are routinely measurable, they may support individualized clinical management in LTCFs. The proposed approach is not a dosing algorithm, but a practical strategy for integrating biological vulnerability into safer prescribing, deprescribing, monitoring, and nutritional care.
No takes yet. Share an insight, caveat, or question.
Norifumi Kudeken (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: